Phase
Condition
Rhinitis, Allergic, Perennial
Allergy
Common Cold
Treatment
N/AClinical Study ID
Ages 18-55 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Provision of written informed consent to participate (prior to any study-relatedprocedures being performed) as shown by a signature on the volunteer consent form andto be able to adhere to the study restrictions and examination schedule
Subjects with confirmed history of seasonal allergic rhinitis to grass pollen (bydirect questioning of presence of positive skin prick test to pollen and History ofSymptoms of allergic rhinitis) within the previous two years
Positive skin prick test to timothy grass pollen (wheal difference with negativecontrol ≥ 3 mm) at screening
Subjects with positive response to screening nasal challenge with increasing doses oftimothy grass pollen (Symptoms worsening with respect to the response to the diluentchallenge of ≥4 points in the total nasal symptom score [TNSS]) within one hour afterlast nasal allergen challenge
Screening and baseline FEV1 >80% predicted and FEV1/FVC > 70% predicted
Exclusion
Exclusion Criteria:
Symptoms of allergic rhinitis within 2 weeks prior to screening
Upper respiratory infection or sinusitis within 14 days of screening and also within 14 days of study start in each of the two periods
Structural nasal abnormalities or nasal polyps on examination, a history of nosebleeding or recent nasal surgery
History of asthma or asthmatic symptoms or other respiratory disease other thanrhinitis within the last 2 years or FEV1<80% of predicted at screening or baseline
Study Design
Connect with a study center
Parexel International GmbH
Berlin, 14050
GermanySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.